4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-17-022050
CIK 0000827871operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:36 PM ET
Size
5.5 KB
Accession
0001209191-17-022050
Insider Transaction Report
Form 4
Edlin Richard A.
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-03-17+10,000→ 10,000 totalExercise: $81.27Exp: 2027-03-16→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]One-third of the shares will vest annually over a three-year period such that the option is fully vested on the third anniversary of the date of grant, subject to the reporting person's continuous service with the issuer through each such vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:36 PM ET
- Size
- 5.5 KB